Shoulder device under 10-Year watch

NCT ID NCT03423953

Ongoing Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 194 people who received the Comprehensive Nano shoulder device to replace their shoulder joint due to arthritis, bone death, or deformity. Researchers will track how long the implant lasts and how well patients can use their shoulder over 10 years. The goal is to gather real-world data on safety and performance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Comprehensive Nano shoulder device
What this could lead to: If successful, this could confirm the device's long-term safety and effectiveness for shoulder replacement.
What could go wrong: This is an observational post-market study, not a controlled trial, so results may not prove the device is better than alternatives. Risks include typical surgery complications like infection or implant failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis osteoarthritis osteonecrosis rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AVASCULAR NECROSIS CORRECTION OF FUNCTIONAL DEFORMITY OSTEOARTHRITIS REVISION RHEUMATOID ARTHRITIS

Contacts and locations

Locations

Chonnam National University Hospital

Gwangju, Gwangju, South Korea
Kingston General Hospital

Kingston, Ontario, K7L 3N6, Canada
Privatklinik Leech

Graz, Styria, 8010, Austria
Samsung Medical Centre

Seoul, Seoul, 06351, South Korea
University of Liverpool

Liverpool, Merseyside, L69 3BX, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.